# A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II

> **NCT04130191** · — · COMPLETED · sponsor: **Shire** · enrollment: 140 (actual)

## Conditions studied

- Hereditary Angioedema (HAE)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04130191
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-11
- **Primary completion:** 2024-09-09
- **Final completion:** 2024-09-09
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2025-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04130191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04130191, "A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04130191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*